scholarly article | Q13442814 |
P356 | DOI | 10.1002/ANIE.201601116 |
P698 | PubMed publication ID | 27226395 |
P50 | author | Santanu Mondal | Q57166426 |
Ulrich Schweizer | Q40281900 | ||
Govindasamy Mugesh | Q42847854 | ||
P2093 | author name string | Karuppusamy Raja | |
P2860 | cites work | Kcne2 deletion uncovers its crucial role in thyroid hormone biosynthesis | Q21128678 |
Purification of a novel flavoprotein involved in the thyroid NADPH oxidase. Cloning of the porcine and human cdnas | Q22010938 | ||
Molecular cloning and expression of novel sulphotransferase-like cDNAs from human and rat brain | Q22253263 | ||
Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family | Q22254073 | ||
Tyrosine cross-linking of extracellular matrix is catalyzed by Duox, a multidomain oxidase/peroxidase with homology to the phagocyte oxidase subunit gp91phox | Q24291589 | ||
Dual oxidase-2 has an intrinsic Ca2+-dependent H2O2-generating activity | Q24306096 | ||
Thyroxine-thyroid hormone receptor interactions | Q24306229 | ||
Differential regulation of dual NADPH oxidases/peroxidases, Duox1 and Duox2, by Th1 and Th2 cytokines in respiratory tract epithelium | Q24316416 | ||
Purification, molecular cloning, and functional expression of the human nicodinamide-adenine dinucleotide phosphate-regulated thyroid hormone-binding protein | Q24317804 | ||
Structural and functional characterization of the two human ThOX/Duox genes and their 5'-flanking regions | Q24323411 | ||
CRYM mutations cause deafness through thyroid hormone binding properties in the fibrocytes of the cochlea | Q24338496 | ||
A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene | Q24533141 | ||
Allan-Herndon-Dudley syndrome and the monocarboxylate transporter 8 (MCT8) gene | Q24533641 | ||
A novel RNA binding protein, SBP2, is required for the translation of mammalian selenoprotein mRNAs | Q24601998 | ||
Caenorhabditis elegans and human dual oxidase 1 (DUOX1) "peroxidase" domains: insights into heme binding and catalytic activity | Q24651445 | ||
Crystal structure of iodotyrosine deiodinase, a novel flavoprotein responsible for iodide salvage in thyroid glands | Q24657898 | ||
Hyperthyroidism. | Q55044265 | ||
Mechanism of simultaneous iodination and coupling catalyzed by thyroid peroxidase. | Q55066489 | ||
Thyroid hormones-From Crystal Packing to Activity to Reactivity | Q56990455 | ||
Structure Elucidation and Characterization of Different Thyroxine Polymorphs | Q57258591 | ||
Appearance of Serine upon Alkaline Incubation of Iodinated Polytyrosine | Q58937744 | ||
Two nuclear signalling pathways for vitamin D | Q59098586 | ||
Deiodination of Thyroid Hormones by Iodothyronine Deiodinase Mimics: Does an Increase in the Reactivity Alter the Regioselectivity? | Q59305152 | ||
Inhibition of peroxidase-catalyzed protein tyrosine nitration by antithyroid drugs and their analogues | Q59305172 | ||
Bioinorganic chemistry aspects of the inhibition of thyroid hormone biosynthesis by anti-hyperthyroid drugs | Q59305185 | ||
Radioiodine and the treatment of hyperthyroidism: the early history | Q46644163 | ||
Anti-thyroid drugs and thyroid hormone synthesis: effect of methimazole derivatives on peroxidase-catalyzed reactions | Q46774019 | ||
Effects of long-term oral administration of levothyroxine sodium on glucose dynamics in healthy adult horses | Q46826949 | ||
A structural role for hormone in the thyroid hormone receptor. | Q46828407 | ||
Regioselective deiodination of iodothyronamines, endogenous thyroid hormone derivatives, by deiodinase mimics. | Q46861556 | ||
3-Iodothyronamine: a novel hormone controlling the balance between glucose and lipid utilisation | Q46969736 | ||
Halogen bonding in supramolecular chemistry | Q47434521 | ||
Distal Conformation of the Thyroid Hormone 3,5,3′-Triiodo-L-Thyronine | Q47979081 | ||
Structures of human transthyretin complexed with thyroxine at 2.0 A resolution and 3',5'-dinitro-N-acetyl-L-thyronine at 2.2 A resolution | Q47983806 | ||
Structural relationships among members of the mammalian sulfotransferase gene family | Q48062109 | ||
Primary structure of bovine lactoperoxidase, a fourth member of a mammalian heme peroxidase family | Q48221801 | ||
Finding the Way into the Brain without MCT8 | Q48261278 | ||
Deiodination and deconjugation of the glucuronide conjugates of the thyroid hormones by rat liver and brain microsomes | Q48485112 | ||
Efficient Activation of Pathogenic ΔPhe501 Mutation in Monocarboxylate Transporter 8 by Chemical and Pharmacological Chaperones | Q48569584 | ||
Successful treatment of hyperthyroidism due to nonneoplastic pituitary TSH hypersecretion with 3,5,3'-triiodothyroacetic acid (TRIAC). | Q48802029 | ||
Tyrosine kinase inhibitors noncompetitively inhibit MCT8-mediated iodothyronine transport | Q48819442 | ||
Metabolism of 3,3'-diiodothyronine in rat hepatocytes: interaction of sulfation with deiodination | Q51641286 | ||
Thyroid hormone receptor beta-specific agonist GC-1 increases energy expenditure and prevents fat-mass accumulation in rats. | Q51758342 | ||
A mutation in the thyroid hormone receptor alpha gene | Q51836050 | ||
Duox expression and related H2O2 measurement in mouse thyroid: onset in embryonic development and regulation by TSH in adult | Q51992958 | ||
Analysis of thyroid hormone binding to human serum prealbumin by 8-anilinonaphthalene-1-sulfonate fluorescence | Q52809628 | ||
Negative cooperativity in the binding of thyroxine to human serum prealbumin. Preparation of tritium-labeled 8-anilino-1-naphthalenesulfonic acid | Q52883960 | ||
Thyroid function is maintained despite increased oxidative stress in mice lacking selenoprotein biosynthesis in thyroid epithelial cells | Q52889450 | ||
Does the aromatic L-amino acid decarboxylase contribute to thyronamine biosynthesis? | Q52891941 | ||
Monocarboxylate transporter 8 deficiency: altered thyroid morphology and persistent high triiodothyronine/thyroxine ratio after thyroidectomy | Q52893640 | ||
Regioselective deiodination of thyroxine by iodothyronine deiodinase mimics: an unusual mechanistic pathway involving cooperative chalcogen and halogen bonding | Q53184269 | ||
Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism | Q44273685 | ||
Effect of iodide on nicotinamide adenine dinucleotide phosphate oxidase activity and Duox2 protein expression in isolated porcine thyroid follicles | Q44363919 | ||
Selenenyl iodide: a new substrate for mammalian thioredoxin reductase | Q44581030 | ||
Effects of the thyroid hormone receptor agonist GC-1 on metabolic rate and cholesterol in rats and primates: selective actions relative to 3,5,3'-triiodo-L-thyronine | Q44710448 | ||
Biomimetic studies on anti-thyroid drugs and thyroid hormone synthesis | Q44783180 | ||
High resolution crystal structures of piscine transthyretin reveal different binding modes for triiodothyronine and thyroxine. | Q44843432 | ||
Comparison of the effects of 3,5,3'-triiodothyroacetic Acid and triiodothyronine on goiter prevention and involution and on hepatic and skeletal parameters in rats | Q44905326 | ||
Endoproteolytic cleavage of human thyroperoxidase: role of the propeptide in the protein folding process. | Q45182296 | ||
Neuronal 3',3,5-triiodothyronine (T3) uptake and behavioral phenotype of mice deficient in Mct8, the neuronal T3 transporter mutated in Allan-Herndon-Dudley syndrome. | Q45916533 | ||
Autocatalytic processing of heme by lactoperoxidase produces the native protein-bound prosthetic group. | Q46031301 | ||
Familial dysalbuminemic hyperthyroxinemia: a persistent diagnostic challenge | Q46090434 | ||
Thyronamines are substrates for human liver sulfotransferases | Q46181887 | ||
Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist | Q46203504 | ||
Thyroid Na+/I- symporter. Mechanism, stoichiometry, and specificity | Q46213441 | ||
Antithyroid drug carbimazole and its analogues: synthesis and inhibition of peroxidase-catalyzed iodination of L-tyrosine | Q46293364 | ||
The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus | Q46410820 | ||
Expression of recombinant membrane-bound type I iodothyronine deiodinase in yeast | Q46547263 | ||
Co-activators and co-repressors in the integration of transcriptional responses | Q46623959 | ||
Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats. | Q46628567 | ||
Deiodinases: implications of the local control of thyroid hormone action | Q24669858 | ||
Structural mechanism for the carriage and release of thyroxine in the blood | Q24671069 | ||
Structural basis of albumin-thyroxine interactions and familial dysalbuminemic hyperthyroxinemia | Q24671472 | ||
New insights into the structure and mechanism of iodothyronine deiodinases | Q26782687 | ||
Clinical Consequences of Mutations in Thyroid Hormone Receptor-α1 | Q26830635 | ||
The syndromes of reduced sensitivity to thyroid hormone | Q27006848 | ||
X-ray crystal structure and characterization of halide-binding sites of human myeloperoxidase at 1.8 A resolution | Q27622235 | ||
X-ray crystal structure of canine myeloperoxidase at 3 A resolution | Q27642075 | ||
Gaining ligand selectivity in thyroid hormone receptors via entropy | Q27658273 | ||
Allosteric Modulation of Hormone Release from Thyroxine and Corticosteroid-binding Globulins | Q27666981 | ||
Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade | Q27679360 | ||
Crystal structure of mammalian selenocysteine-dependent iodothyronine deiodinase suggests a peroxiredoxin-like catalytic mechanism | Q27684581 | ||
Crystal structure of mouse mu-crystallin complexed with NADPH and the T3 thyroid hormone | Q27688986 | ||
Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 A | Q27729158 | ||
Structural determinants of nuclear receptor assembly on DNA direct repeats | Q27730227 | ||
The steroid and thyroid hormone receptor superfamily | Q27861095 | ||
Selenium, the thyroid, and the endocrine system. | Q27863337 | ||
Nuclear-receptor ligands and ligand-binding domains | Q28139440 | ||
Thyroid oxidase (THOX2) gene expression in the rat thyroid cell line FRTL-5 | Q28141231 | ||
Substitution of Cysteine for Selenocysteine in the Catalytic Center of Type III Iodothyronine Deiodinase Reduces Catalytic Efficiency and Alters Substrate Preference | Q28204014 | ||
Iodothyronine deiodinases | Q28207768 | ||
The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance | Q28209900 | ||
Characterization of ThOX proteins as components of the thyroid H(2)O(2)-generating system | Q28217122 | ||
Transcriptional control. Sinful repression | Q28237278 | ||
What's up and down with histone deacetylation and transcription? | Q28238059 | ||
Transcriptional regulation by nonclassical action of thyroid hormone | Q28245384 | ||
3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone | Q28261976 | ||
Alternate pathways of thyroid hormone metabolism | Q28269698 | ||
The thyroid hormone-inactivating deiodinase functions as a homodimer | Q28273439 | ||
Human myeloperoxidase and thyroid peroxidase, two enzymes with separate and distinct physiological functions, are evolutionarily related members of the same gene family | Q28281160 | ||
micro-Crystallin as an intracellular 3,5,3'-triiodothyronine holder in vivo | Q28285860 | ||
Antithyroid drugs and their analogues: synthesis, structure, and mechanism of action | Q28295146 | ||
Identification of a truncated dual oxidase 2 (DUOX2) messenger ribonucleic acid (mRNA) in two rat thyroid cell lines. Insulin and forskolin regulation of DUOX2 mRNA levels in FRTL-5 cells and porcine thyrocytes | Q28565613 | ||
Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10 | Q34761270 | ||
Spatial requirement for coupling of iodotyrosine residues to form thyroid hormones | Q35049083 | ||
Insights into molecular properties of the human monocarboxylate transporter 8 by combining functional with structural information | Q35161452 | ||
Mode of binding of the antithyroid drug propylthiouracil to mammalian haem peroxidases | Q35167515 | ||
Ether link cleavage is the major pathway of iodothyronine metabolism in the phagocytosing human leukocyte and also occurs in vivo in the rat. | Q35205716 | ||
Biosynthesis of 3-Iodothyronamine From T4 in Murine Intestinal Tissue | Q35766763 | ||
Selective thyroid hormone receptor-beta activation: a strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability | Q35812012 | ||
Mechanism of the nuclear receptor molecular switch | Q35846738 | ||
Thyroid hormone transporters | Q36053024 | ||
Antithyroid drugs | Q36061115 | ||
Recombinant apolipoprotein A-IMilano for the treatment of cardiovascular diseases. | Q36410620 | ||
Selenocysteine incorporation machinery and the role of selenoproteins in development and health | Q36557525 | ||
Regulation of Nox and Duox enzymatic activity and expression | Q36865824 | ||
New targets of high-density lipoprotein therapy. | Q36874838 | ||
Clinical and Hormonal Outcome After Two Years of Triiodothyroacetic Acid Treatment in a Child with Thyroid Hormone Resistance | Q36888415 | ||
Triiodothyronine, Thyroxine, and Iodine in Purified Thyroglobulin from Patients with Graves' Disease | Q37044919 | ||
Inhibiting transthyretin amyloid fibril formation via protein stabilization | Q37082709 | ||
Effects of thyroid hormone analogs on lipid metabolism and thermogenesis | Q37085953 | ||
Adjunctive interventions in myocardial infarction: the role of statin therapy | Q37140087 | ||
Radioiodine therapy (RAI) for Graves' disease (GD) and the effect on ophthalmopathy: a systematic review | Q37145112 | ||
Peroxides and peroxide-degrading enzymes in the thyroid | Q37170919 | ||
Genetics of crystallins: cataract and beyond. | Q37325114 | ||
Thyronamines are isozyme-specific substrates of deiodinases. | Q37325285 | ||
Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes | Q37428723 | ||
Excess thyroid hormone and carbohydrate metabolism | Q37443390 | ||
Compounds I of catalase and horse radish peroxidase: pi-cation radicals | Q37471535 | ||
The Na+/I- symporter (NIS): mechanism and medical impact. | Q37494004 | ||
Se- and s-based thiouracil and methimazole analogues exert different inhibitory mechanisms on type 1 and type 2 deiodinases | Q37582437 | ||
A redundant role of human thyroid peroxidase propeptide for cellular, enzymatic, and immunological activity | Q37587910 | ||
Disorders of selenium metabolism and selenoprotein function | Q37889072 | ||
Selective thyromimetics using receptor and tissue selectivity approaches: prospects for dyslipidemia | Q38003421 | ||
Function of thyroid hormone transporters in the central nervous system | Q38034373 | ||
Type 3 deiodinase and solid tumors: an intriguing pair. | Q38132760 | ||
Endocrine side-effects of anti-cancer drugs: thyroid effects of tyrosine kinase inhibitors | Q38212155 | ||
Comparative Efficacy and Side Effects of the Treatment of Euthyroid Goiter with Levo-Thyroxine or Triiodothyroacetic Acid | Q34275012 | ||
Thyroid hormone inactivation in gastrointestinal stromal tumors | Q34294545 | ||
Mechanisms of thyroid hormone action | Q34297363 | ||
Adaptive thermogenesis in adipocytes: is beige the new brown? | Q34326605 | ||
Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation | Q34359445 | ||
Inhibition of the type 2 iodothyronine deiodinase underlies the elevated plasma TSH associated with amiodarone treatment | Q34392670 | ||
Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans | Q34446531 | ||
Biochemical mechanisms of thyroid hormone deiodination | Q34446850 | ||
Mutations in SECISBP2 result in abnormal thyroid hormone metabolism | Q34460050 | ||
3-iodothyronamine differentially modulates α-2A-adrenergic receptor-mediated signaling | Q34471875 | ||
Studies of the hormonal regulation of type 2 5'-iodothyronine deiodinase messenger ribonucleic acid in pituitary tumor cells using semiquantitative reverse transcription-polymerase chain reaction | Q34481775 | ||
Substrate cycling between gluconeogenesis and glycolysis in euthyroid, hypothyroid, and hyperthyroid man. | Q34549482 | ||
Negative feedback regulation of hypophysiotropic thyrotropin-releasing hormone (TRH) synthesizing neurons: role of neuronal afferents and type 2 deiodinase. | Q34580551 | ||
Mutations of the thyroid hormone transporter MCT8 cause prenatal brain damage and persistent hypomyelination | Q34628350 | ||
??? | Q28330379 | ||
Anti-obesity, anti-diabetic, and lipid lowering effects of the thyroid receptor beta subtype selective agonist KB-141. | Q38289306 | ||
Structure and function of thyroid hormone plasma membrane transporters | Q38299941 | ||
Thyroid hormone transporters--functions and clinical implications | Q38460012 | ||
Pendrin and anoctamin as mediators of apical iodide efflux in thyroid cells | Q38575098 | ||
Activated Thyroid Hormone Promotes Differentiation and Chemotherapeutic Sensitization of Colorectal Cancer Stem Cells by Regulating Wnt and BMP4 Signaling | Q38811169 | ||
Structure-activity relationships of 44 halogenated compounds for iodotyrosine deiodinase-inhibitory activity | Q39099130 | ||
Histidines in potential substrate recognition sites affect thyroid hormone transport by monocarboxylate transporter 8 (MCT8). | Q39164972 | ||
The oxidation of diiodotyrosine derivatives | Q39419858 | ||
Coordination behaviour of antithyroid drugs against the Fe(I)(NO)2 group in solution: ESR and FT-NMR study | Q39487445 | ||
Raised total thyroxine and free thyroxine index but normal free thyroxine. A serum abnormality due to inherited increased affinity of iodothyronines for serum binding protein | Q39539517 | ||
Phenolic and nonphenolic ring deiodinations of iodothyronines in cultured hepatocarcinoma cell hemogenate from monkey | Q39654068 | ||
Formation and Metabolism of 3',5'-Diiodothyronine and 3,5-Diiodothyronine by Cultured Monkey Hepatocarcinoma Cells | Q39665480 | ||
Liganded thyroid hormone receptor-alpha enhances proliferation of pancreatic beta-cells | Q39696047 | ||
Thyroid peroxidase forms thionamide-sensitive homodimers: relevance for immunomodulation of thyroid autoimmunity | Q39814238 | ||
Thyronamines inhibit plasma membrane and vesicular monoamine transport | Q40127597 | ||
Ubiquitination-induced conformational change within the deiodinase dimer is a switch regulating enzyme activity. | Q40142318 | ||
Biochemistry and molecular biology of drug-metabolizing sulfotransferase | Q40590232 | ||
Functional characterization of pendrin in a polarized cell system. Evidence for pendrin-mediated apical iodide efflux | Q40600626 | ||
The management of hyperthyroidism | Q40622969 | ||
Role of sulfation in thyroid hormone metabolism | Q40673360 | ||
Loop variants of the serpin thyroxine-binding globulin: implications for hormone release upon limited proteolysis | Q40740571 | ||
Iodide transport in the thyroid gland | Q40914751 | ||
Nutritional and hormonal regulation of thyroid hormone deiodinases | Q40926105 | ||
3,5-Diiodo-L-thyronine (T2) has selective thyromimetic effects in vivo and in vitro | Q41085267 | ||
The evolution of gene expression, structure and function of transthyretin | Q41477900 | ||
Amyloid fibril formation and protein misassembly: a structural quest for insights into amyloid and prion diseases | Q41509791 | ||
Glucuronidation of thyroid hormone by human bilirubin and phenol UDP-glucuronyltransferase isoenzymes | Q41547066 | ||
Substitution of cysteine for selenocysteine in type I iodothyronine deiodinase reduces the catalytic efficiency of the protein but enhances its translation | Q41600994 | ||
Importance of the content and localization of tyrosine residues for thyroxine formation within the N-terminal part of human thyroglobulin | Q42066388 | ||
Further observations on the oxidation of di-idotyrosine derivatives | Q42138421 | ||
Essential molecular determinants for thyroid hormone transport and first structural implications for monocarboxylate transporter 8. | Q42430465 | ||
Activation of dual oxidases Duox1 and Duox2: differential regulation mediated by camp-dependent protein kinase and protein kinase C-dependent phosphorylation | Q42447798 | ||
Generation of H2O2in Isolated Porcine Thyroid Follicles* | Q42454298 | ||
Iodothyronamines are oxidatively deaminated to iodothyroacetic acids in vivo | Q42724891 | ||
A chemical model for the inner-ring deiodination of thyroxine by iodothyronine deiodinase | Q42860757 | ||
Deiodination of L-thyroxine and its activity on the oxidation in vitro of reduced nicotinamide-adenine dinucleotide by peroxidase plus hydrogen peroxide | Q42924359 | ||
TRbeta is the critical thyroid hormone receptor isoform in T3-induced proliferation of hepatocytes and pancreatic acinar cells. | Q42967079 | ||
Is halogen bonding the basis for iodothyronine deiodinase activity? | Q43053882 | ||
Adaptations of the autonomous nervous system controlling heart rate are impaired by a mutant thyroid hormone receptor-alpha1. | Q43130282 | ||
Modeling of the 5'-deiodination of thyroxine by iodothyronine deiodinase: chemical corroboration of a selenenyl iodide intermediate | Q43226751 | ||
In vitro effect of Triac on resistance to thyroid hormone receptor mutants: potential basis for therapy | Q43577801 | ||
Characterization of T(4)-binding globulin cleaved by human leukocyte elastase | Q43913897 | ||
Biomimetic studies on iodothyronine deiodinase intermediates: modeling the reduction of selenenyl iodide by thiols | Q43990586 | ||
Peroxidatic degradation and ether link cleavage of thyroxine in a particulate fraction of human thyroid | Q44043394 | ||
Requirement for thyroid hormone receptor beta in T3 regulation of cholesterol metabolism in mice | Q44081203 | ||
Type I iodothyronine deiodinase is a selenocysteine-containing enzyme | Q28566196 | ||
Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index | Q28567896 | ||
Activation of the hepatic LDL receptor promoter by thyroid hormone | Q28578162 | ||
Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter | Q28580639 | ||
Secisbp2 is essential for embryonic development and enhances selenoprotein expression | Q28585049 | ||
Molecular mechanisms of action of steroid/thyroid receptor superfamily members | Q29547540 | ||
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein | Q29547752 | ||
Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors | Q29615768 | ||
The importance of thyroglobulin structure for thyroid hormone biosynthesis | Q30304132 | ||
3,5-Diiodo-L-thyronine (3,5-t2) exerts thyromimetic effects on hypothalamus-pituitary-thyroid axis, body composition, and energy metabolism in male diet-induced obese mice. | Q30367886 | ||
Tyrosine 130 Is an Important Outer Ring Donor for Thyroxine Formation in Thyroglobulin | Q30472573 | ||
Molecular evolution of the reactive oxygen-generating NADPH oxidase (Nox/Duox) family of enzymes | Q33290000 | ||
In vitro and mouse studies supporting therapeutic utility of triiodothyroacetic acid in MCT8 deficiency | Q33631892 | ||
Expression of uncoupling protein 1 in mouse brown adipose tissue is thyroid hormone receptor-beta isoform specific and required for adaptive thermogenesis | Q33634049 | ||
Local activation and inactivation of thyroid hormones: the deiodinase family | Q33690340 | ||
Thyroid hormone regulation of metabolism | Q33707954 | ||
Administration of 3,5-diiodothyronine (3,5-T2) causes central hypothyroidism and stimulates thyroid-sensitive tissues | Q33710032 | ||
A novel mutation in the Albumin gene (R218S) causing familial dysalbuminemic hyperthyroxinemia in a family of Bangladeshi extraction. | Q33713753 | ||
The Oxidation of 3,5-Diiodotyrosine to Thyroxine | Q33746596 | ||
The syndrome of inherited partial SBP2 deficiency in humans | Q33830119 | ||
The thyroxine-binding proteins | Q33863834 | ||
Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice | Q33900633 | ||
Mutations in the iodotyrosine deiodinase gene and hypothyroidism | Q34011307 | ||
Evolution of the thyroid hormone-binding protein, transthyretin | Q34052572 | ||
Mice deficient in MCT8 reveal a mechanism regulating thyroid hormone secretion | Q34090117 | ||
Trans-suppression of misfolding in an amyloid disease. | Q34092993 | ||
Genetics and phenomics of hypothyroidism and goiter due to iodotyrosine deiodinase (DEHAL1) gene mutations | Q34105087 | ||
Hormone binding globulins undergo serpin conformational change in inflammation | Q34167746 | ||
Halogenated Phenolic Contaminants Inhibit the In Vitro Activity of the Thyroid-Regulating Deiodinases in Human Liver | Q34184614 | ||
The iodothyronine selenodeiodinases are thioredoxin-fold family proteins containing a glycoside hydrolase clan GH-A-like structure | Q34212193 | ||
Mechanism of anion selectivity and stoichiometry of the Na+/I- symporter (NIS). | Q34225585 | ||
Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function | Q34255957 | ||
Identification of iopanoic acid as substrate of type 1 deiodinase by a novel nonradioactive iodide-release assay. | Q34262575 | ||
Selective modulation of thyroid hormone receptor action. | Q34268820 | ||
P433 | issue | 27 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 7606-7630 | |
P577 | publication date | 2016-05-25 | |
P13046 | publication type of scholarly work | review article | Q7318358 |
P1433 | published in | Angewandte Chemie International Edition | Q62023953 |
P1476 | title | Chemistry and Biology in the Biosynthesis and Action of Thyroid Hormones | |
P478 | volume | 55 |
Q90399144 | A Halogen Bonding Perspective on Iodothyronine Deiodinase Activity |
Q37743404 | A post-publication analysis of the idealized upper reference value of 2.5 mIU/L for TSH: Time to support the thyroid axis with magnesium and iron especially in the setting of reproduction medicine |
Q89460321 | A review of select minerals influencing the haematopoietic process |
Q33903155 | An extremely high dietary iodide supply forestalls severe hypothyroidism in Na+/I- symporter (NIS) knockout mice |
Q94481800 | Application of principal component analysis and logistic regression model in lupus nephritis patients with clinical hypothyroidism |
Q55204269 | Association of metabolic risks with subclinical hypothyroidism: A cross-sectional analysis. |
Q52364453 | Biochemical properties of thyroid peroxidase (TPO) expressed in human breast and mammary-derived cell lines |
Q47588788 | GLIS3 is indispensable for TSH/TSHR-dependent thyroid hormone biosynthesis and follicular cell proliferation. |
Q63352451 | Genome-wide association meta-analysis for total thyroid hormone levels in Croatian population |
Q55261899 | Gestational Hypothyroxinemia Affects Its Offspring With a Reduced Suppressive Capacity Impairing the Outcome of the Experimental Autoimmune Encephalomyelitis. |
Q91692357 | Halogen Bonding from the Bonding Perspective with Considerations for Mechanisms of Thyroid Hormone Activation and Inhibition |
Q48124192 | Halogen-Bonding Interactions of Polybrominated Diphenyl Ethers and Thyroid Hormone Derivatives: A Potential Mechanism for the Inhibition of Iodothyronine Deiodinase |
Q47878350 | Selenium and Selenocysteine in Protein Chemistry |
Q47142211 | The Association of Thyroid Disease and Oral Lichen Planus: A Literature Review and Meta-analysis |
Q93151631 | The Colorful Diversity of Thyroid Hormone Metabolites |
Q89557180 | The structure of human thyroglobulin |
Q50026830 | Thyroid hormone receptor localization in target tissues |
Q99594721 | Thyroxine binding to type III iodothyronine deiodinase |
Search more.